Innovations in endothelial keratoplasty


Sean Henahan
Published: Friday, April 17, 2015

Two of the latest iterations of endothelial keratoplasty have the potential to simplify surgery and to make more efficient use of donor tissue, Gerrit Melles MD, PHD , Director, Netherlands Institute for Innovative Ocular Surgery (NIIOS), told a session of the World Cornea Congress VII in San Diego.Dr Melles, who played a key role in the development of Descemet’s membrane endothelial keratoplasty (DMEK), discussed hemi-DMEK and Descemet’s membrane mediated endothelial transfer (DMET).
Hemi-DMEK involves dissecting the entire Descemet’s membrane, then cutting it in half so that there are two half moon shaped grafts. The surgical technique is the same as DMEK, but requires a different technique at the eye bank. Visual acuity results are also similar to those seen with standard DMEK procedure, with the principle advantage being that one donor cornea can be used for procedures.
DMET involves injecting free-floating donor Descemet’s cells in the recipient anterior chamber after performing a descemetorhexis on the host. The procedure is less complicated than DMEK, and has proven effective in the treatment of Fuch’s dystrophy. However, it takes longer for the cornea to clear with DMET than with DMEK, Dr Melles reported.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.